ExonHit Therapeutics Inc. Receives € 1.93 Million from OSEO Within the Personalized Medicine TEDAC Project in Cancer
6/5/2012 10:32:56 AM
More...
|
ExonHit Therapeutics Inc. is Beneficiary of a Grant from the European Union Within the Responsify Consortium
3/5/2012 10:09:13 AM
More...
|
ExonHit Therapeutics Inc.: AclarusDx®: Launch of Observational Study in France
12/12/2011 10:49:57 AM
More...
|
ExonHit Therapeutics Inc. Extends Strategic Collaboration with Allergan Inc. (AGN)
11/2/2011 7:39:45 AM
More...
|
Approval of US Pilot Clinical Trial to Evaluate AclarusDx(™), the ExonHit Therapeutics Inc. Investigational Test for Alzheimer’s Disease Diagnosis
10/26/2011 11:14:59 AM
More...
|
ExonHit Therapeutics Inc. and Beijing Genomics Institute (BGI) Announce Successful Completion of a Promising Next-Generation Sequencing Project
7/25/2011 11:00:10 AM
More...
|
ExonHit Therapeutics Inc. Announces Successful Completion of the Second Phase of EHT Dx14 Clinical Validation
7/19/2011 11:12:45 AM
More...
|
ExonHit Therapeutics Inc. Reports Key Progress in the Introduction of AclarusDx(TM) in the French IVD Market
6/29/2011 10:53:00 AM
More...
|
ExonHit Therapeutics Inc.'s Extraordinary Shareholders’ Meeting
5/18/2011 10:33:53 AM
More...
|
ExonHit Therapeutics Inc. Announces Publication of EHT 0202 Phase IIa Results in Current Alzheimer Research
4/5/2011 10:41:15 AM
More...
|
|